News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Potent Anti-tumor PARP Inhibitor Discovered by LEAD Therapeutics, Inc.



11/16/2009 9:32:19 AM

Bookmark and Share

SAN BRUNO, Calif. & SHANGHAI--(BUSINESS WIRE)--LEAD Therapeutics, a privately held drug discovery company, today announced the discovery of a novel, orally available, PARP inhibitor with potent anti-tumor activity both as single-agent treatment and in combination with chemotherapy drugs. The new compound, designated LT-673, is in preclinical development as a potential cancer therapeutic.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES